secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2023-04-03T23:59:59+00:00
Accession:  0001193125-23-088888
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx enters agreement with Stanford to seek Supreme Court review of patent validity; royalties suspended
--------------------------------------------------------------------------------

- Agreement dated March 29, 2023, effective Feb 3, 2023, with Stanford to seek Supreme Court review of Federal Circuit patent decision.
- Royalty payment and reporting obligations on U.S. licensed products suspended during pendency of Supreme Court review.
- Company's 30-day termination right under exclusive license agreement is also suspended during review.
- Agreement modifies post-termination obligations and allocation of legal fees between the parties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000119312523088888/0001193125-23-088888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000119312523088888/d477855d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-088888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer